Cannabis Science (CBIS) Moves Forward with Critical Support of Landmark Federal Cannabis Legislative Initiative

COLORADO SPRINGS, Colo.— (CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development, is a key leader in the private sector challenge to end the restrictions on cannabis drug development and research in the U.S. “The Cannabinoid Scientific Research and Development Act,” which will be submitted for congressional review in the U.S. […]

Read More

Research Doesn’t Support Use Of Medical Marijuana

Based on science and concern about young minds and the safety of our citizens, we believe that the crude drugs from the plant Cannabis should be illegal.  There are differing views on this issue.  In our democracy, divergent views are expected.  The more personal the issue, the more passionate and less logical the discussion. Media […]

Read More